DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) mutations limit normal and autoreactive CD4+ T follicular helper responses and attenuate T cell-driven joint inflammation - Quiz - MDSpire

Mutations in DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) impair both typical and autoreactive CD4+ T follicular helper cell functions and reduce T cell-mediated joint inflammation

  • By

  • Yunbing Shen

  • Sanjaykumar Boddul

  • Zhaojun Li

  • Zsolt Kasza

  • Marlene Schülein

  • Bruno Raposo

  • Karine Chemin

  • Per-Johan Jakobsson

  • Alexander Espinosa

  • Lars Klareskog

  • Fredrik Wermeling

  • June 29, 2026

Share

Original Source(s)

DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) mutations limit normal and autoreactive CD4+ T follicular helper responses and attenuate T cell-driven joint inflammation

  • by Yunbing Shen, Sanjaykumar Boddul, Zhaojun Li, Zsolt Kasza, Marlene Schülein, Bruno Raposo, Karine Chemin, Per-Johan Jakobsson, Alexander Espinosa, Lars Klareskog, Fredrik Wermeling

  • June 29, 2026

Related Content

Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and health.

Dual Action of Dipyridamole in Experimental Rheumatoid Arthritis: Suppression of Joint Inflammation and Upregulation of Muscle Anabolism via Adenosine and AMPK Pathways

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.